EGFR and colorectal carcinoma: With encouraging results seen with individually targeting VEGF and EGFR as successful treatment strategies in advanced CRC, it would be logical to consider dual inhibition of angiogenesis and EGFR with support from preclinical data (Ciardiello et al, 2004; Tonra et al, 2006).